Navigation Links
Bionovo Announces 2011 Plan of Action on MF101 (Menerba™)
Date:2/10/2011

EMERYVILLE, Calif., Feb. 10, 2011 /PRNewswire/ -- Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today articulated for investors the Company's plan of action for 2011 in the development of MF101 (Menerba™). The company also updated its investor information, available on the company's website.

"Having positive clinical and non-clinical data to date, regulatory clarity on requirements from the FDA and the EMA, we can confidently proceed in advancing Menerba into pivotal clinical testing," commented Dr. Isaac Cohen, chairman and chief executive officer of Bionovo, Inc. "Our recent successful financing was an additional validation for Menerba's future development toward commercialization. I look forward to concentrating on executing the business plan and proving the validity of our novel drug development process."

The Company's announced activities and milestones during 2011, based on current plans and progress, include:Manufacture of drug material at higher potency for clinical and non-clinical testing.

  Early first quarter.Conduct a 40 patient, 28-day "tolerability" trial at higher doses planned for later studies.

  Late first quarter, early second quarter.Non-clinical study for toxicity in rodents.

  Late first quarter, early second quarter.Manufacture of clinical material for Phase 3 study, using FDA-approved commercial process.

  Second quarter.Complete contracts, IRB approval and training at U.S. clinical sites for the Phase 3 study.

  First and second quarter.Initiate patient recruitment and screening in the Phase 3 study.

  End of the second quarter.Initiate dosing in the Phase 3 study.

  Early in the third quarter.Data Safety Monitoring Board interim revie
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
2. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
5. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
7. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
8. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
9. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
11. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... By now, if you haven,t heard about the ALS Ice ... awareness campaign has brought this devastating disease to the forefront ... Million (and counting) for ALS. Every day, more and more ... as well. One such company, Acorn Stairlifts Inc., ... works with ALS sufferers and helps to provide solutions for ...
(Date:8/27/2014)... 27, 2014  Hill-Rom Holdings, Inc. (NYSE: ... presentation at the Morgan Stanley Global Healthcare Conference on ... You are invited to listen to the live discussion ... access it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A recorded ... after conclusion of the live event and accessible at ...
(Date:8/27/2014)... 2014 North American lighting leader OSRAM SYLVANIA ... for the new OSRAM ITOS ® PHASER ® ... for microscopy, endoscopy and surgical head lamps that delivers the ... and lamp life. "We,re honored to be recognized ... innovative new technologies of the past year," said Andreas ...
Breaking Medicine Technology:Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3
(Date:8/27/2014)... All Canada Goose Parkas from CanadaGooseJackor.nu are great. ... modern. With unique detailing such as buttons, leather trim and ... up in opulence. Recently, the company has unveiled its new ... , True enough, the new assortment comes in various ... 28% off) on all these brand new items. By launching ...
(Date:8/27/2014)... Top 10 Best SEO Hosting, a well-known SEO Hosts Review ... iPage, Bluehost and GoDaddy are the most recommended suppliers for ... buy useful hosting (including VPS and cloud hosting). , ... has been serving hosting small business websites since 1998. With ... leader in the hosting industry for its affordable and easy ...
(Date:8/27/2014)... New Jersey’s own Morgan Hoffmann turned in ... during The Barclays – and thanks to finishing high ... four rounds, stepped his way into raising another $7,500 ... of New Jersey (Horizon BCBNSNJ) Walking Challenge. , Last ... before family and friends at the Paramus course, to ...
(Date:8/27/2014)... topical agents and light to kill tissue) appears to ... caused by sun damage) at three months after treatment ... , Author: Gayatri Patel, M.D., M.P.H., of ... and colleagues. , Background: AKs are rough, ... with fair complexions who have had lots of sun ...
(Date:8/27/2014)... Sound Telecom, a leading telecommunications company that offers ... systems, has unveiled an article titled “ Three Things ... .” The piece examines the world of medical messaging ... compliant with HIPAA and HITECH requirements. , Brian ... Sound Telecom, opens with evidence that the use of ...
Breaking Medicine News(10 mins):Health News:CanadaGooseJackor.nu: 2014 Canada Goose Banff Parkas At Discounted Prices 2Health News:Well-known SEO Hosts Review Site Top10BestSEOHosting.com Recommends iPage, Bluehost and GoDaddy To Webmasters 2Health News:Morgan Hoffmann, PGA TOUR Pro & Wyckoff Native, golfs and walks his way to top 10 finish at The Barclays while raising additional $7,500 for charity 2Health News:Photodynamic therapy vs. cryotherapy for actinic keratoses 2Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 2Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 3
... ... Conference April 2010 , ... Orlando, FL (PRWEB) April 9, 2010 -- Distance learning services provider Compass Knowledge ... Dr. Fredrick Snow, and Dr. Larry Pawola, Clinical Associate Professor and Interim Head, ...
... passed the most comprehensive healthcare reform bill since the ... leaves much of the critical work of healthcare reform ... Wachter, Chief of the Division of Hospital Medicine, University ... Society of Hospital Medicine, in the April issue of ...
... ... of the 19th Annual Partnerships in Clinical Trials and located14th Annual eClinical Technology Summit, ... ... Data Management, a nonprofit association that supports data managers and others involved in clinical ...
... a substantial role in the surging number of autism diagnoses, ... of Sociology . The study, by researchers from the ... University, found that children living near a child who has ... of being diagnosed themselves in the following year. The increased ...
... ... Three-Month Report Outlines Next Steps , ... Port au Prince, Haiti (Vocus) April 8, 2010 -- Three months after a 7-magnitude ... , ,However, they still face a host of threats to their well-being, according to ...
... ... and reducing side effects , ... Santa Barbara, Calif. (Vocus) April 8, 2010 -- Researchers have shown that ... into tumor tissue. The peptide has been shown to substantially increase treatment efficacy against ...
Cached Medicine News:Health News:Compass Knowledge Group and University of Illinois at Chicago to Co-Present at UCEA National Conference April 2010 2Health News:Compass Knowledge Group and University of Illinois at Chicago to Co-Present at UCEA National Conference April 2010 3Health News:SCDM to Showcase Professional Development Opportunities at Partnerships Event 2Health News:Study: Social influence playing role in surging autism diagnoses 2Health News:Study: Social influence playing role in surging autism diagnoses 3Health News:Three Months after Haiti Quake, Life Still Perilous for Children 2Health News:Three Months after Haiti Quake, Life Still Perilous for Children 3Health News:Research Reveals Cancer Drug Effectiveness Substantially Advanced 2Health News:Research Reveals Cancer Drug Effectiveness Substantially Advanced 3Health News:Research Reveals Cancer Drug Effectiveness Substantially Advanced 4Health News:Research Reveals Cancer Drug Effectiveness Substantially Advanced 5
Puros allografts is a family of bone products specially designed and processed to meet the demanding needs of spine surgeons. The grafts are processed using the proprietary Tutoplast process....
... Graftech cervical dowels are ... to graft expulsion and improve ... allows immediate red blood cell ... Grafton DBM gel into the ...
8 mm S Graftech cervical spacer....
Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed....
Medicine Products: